Elagolix 834153-87-6
Hoʻohana ʻia kēia lāʻau lapaʻau e nā wahine e kōkua i ka hoʻopau ʻana i ka ʻeha haʻahaʻa a koʻikoʻi ma muli o kahi maʻi i kapa ʻia ʻo endometriosis.
Hiki ke mālama: Endometriosis
Nā inoa inoa: Orilissa
Papa Laau La'au: LHRH (GnRH) Antagonists
Loaʻa: Pono ka ʻōlelo kuhikuhi
Hāpai: Mai hoʻohana i ka wā hāpai
Lactation: E nīnau i ke kauka ma mua o ka hoʻohana ʻana
ʻO Elagolix kahi mea olaola waha, lua-hanauna, non-peptide i hoʻokumu ʻia, pūhui mole liʻiliʻi a me ka hormone hoʻokuʻu gonadotropin-releasing hormone (GnRH; LHRH) receptor antagonist, me ka hana hoʻoneʻe ʻana i ka hormone.Ma ka hoʻoponopono waha, hoʻokūkū ʻo elagolix me GnRH no ka hoʻopaʻa ʻana i ka mea hoʻopaʻa a hoʻopaʻa i ka hōʻailona hōʻailona GnRH i ka pituitary gland anterior.ʻO kēia ka mea e pale ai i ka huna ʻana o ka hormone luteinizing (LH) a me ka follicle stimulating hormone (FSH).I nā kāne, ʻo ka pale ʻana i ka huna LH e pale i ka hoʻokuʻu ʻana o ka testosterone.I nā wahine, ʻo ka pale ʻana i ka FSH a me LH e pale i ka hana ʻana o ka estrogen e nā ovaries.Hiki ke mālama a pale paha i nā hōʻailona o nā maʻi pili i ka hormone sex.
ʻO Elagolix kahi mea kū'ē waha, nonsteroidal gonadotropin hoʻokuʻu i ka hormone (GnRH) e hoʻemi ana i ka hana estrogen a hoʻohana ʻia e mālama i nā ʻano ʻeha o ka endometriosis i nā wahine.Hoʻopili ʻia ka lāʻau ʻo Elagolix me ka haʻahaʻa haʻahaʻa o ka piʻi ʻana o ka enzyme serum i ka wā o ka lāʻau lapaʻau a ʻaʻole naʻe i hoʻopili ʻia i nā manawa o ka hōʻeha ate.
Ua hoʻohana ʻia ʻo Elagolix i nā hoʻokolohua e aʻo ana i ka ʻepekema kumu a me ka mālama ʻana o Endometriosis, Folliculogenesis, Uterine Fibroids, Heavy Uterine Bleeding, a me Heavy Menstrual Bleeding.Ma ka 24 Iulai 2018, akā naʻe, ua ʻae ka US Food and Drug Administration (FDA) i ka elagolix o AbbVie ma lalo o ka inoa inoa ʻo Orilissa ma ke ʻano he mua a me ka waha wale nō ka mea kū'ē i ka gonadotropin-releasing hormone (GnRH) antagonist i kūkulu pono ʻia no nā wahine me ka ʻeha endometriosis haʻahaʻa a koʻikoʻi.Ua hoʻoholo ʻia ʻo ka endometriosis kekahi o nā maʻi gynecologic maʻamau ma ʻAmelika Hui Pū ʻIa.ʻO ka mea nui, hōʻike nā manaʻo hoʻokahi i loko o nā wahine he ʻumi o ka makahiki hānau i ka hopena e ka endometriosis a loaʻa i nā hōʻailona ʻeha.Eia kekahi, hiki i nā wahine i loaʻa i kēia maʻi ke pilikia a hiki i ka ʻeono a hiki i ka ʻumi makahiki a kipa aku i nā kauka he nui ma mua o ka loaʻa ʻana o kahi hōʻailona kūpono.Ma hope mai, ʻoiai ua ʻae ʻia ʻo Orilissa (elagolix) e ka FDA ma lalo o ka loiloi mua, ua hāʻawi kēia ʻae wikiwiki hou i nā limahana mālama ola i kahi koho waiwai ʻē aʻe no ka mālama ʻana i nā pono kūpono ʻole o nā wahine i hoʻopilikia ʻia e ka endometriosis, ma muli o ko lākou ʻano kikoʻī a me ka paʻakikī o ka ʻeha endometriosis. .
ʻO ke kinona
Manaʻo18Nā papahana Loiloi Kūlike Kūlike i ʻae ʻia4, a6nā papahana ma lalo o ka ʻae ʻia.
Ua hoʻokumu ka ʻōnaehana hoʻokele maikaʻi honua kiʻekiʻe i ke kumu kūʻai.
Holo ka nānā ʻana i ka maikaʻi ma ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic.
Kākoʻo ka hui ʻoihana Regulatory Affairs i nā koi maikaʻi i ka wā o ke noi a me ke kau inoa ʻana.